Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Gynecologic 2Gastrointestinal 2

Conditions

Peritoneal Neoplasms 9Ovarian Neoplasms 8Fallopian Tube Neoplasms 5Colorectal Neoplasms 5Carcinoma, Ovarian Epithelial 3Stomach Neoplasms 2Mesothelioma 2Adrenocortical Carcinoma 2Pseudomyxoma Peritonei 1Neoplasms 1Neoplasm Metastasis 1Hyperthermia 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Colonic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1Appendiceal Neoplasms 1Abdominal Neoplasms 1

Interventions

Pemetrexed 10Cisplatin 9Gemcitabine 8Nivolumab 5Ipilimumab 4Carboplatin 4niraparib 3durvalumab 3Vinorelbine 3Bevacizumab 3tremelimumab 2pembrolizumab 2olaparib 2anetumab ravtansine 2Radiotherapy, Intensity-Modulated 2Oxaliplatin 2Imatinib Mesylate 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorodeoxyglucose F18 2Cytoreduction Surgical Procedures 2vandetanib 1tislelizumab 1tazemetostat 1spartalizumab 1sargramostim 1ribociclib 1fludarabine phosphate 1fludarabine 1dostarlimab 1defactinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Mesothelioma × Cytoreduction Surgical Procedures × Clear all
NCT00004547 2015-11-18

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
188 enrolled 11 charts
GastrointestinalGynecologicOther solid neoplasmThoracic

Abdominal Neoplasms, Colonic Neoplasms, Mesothelioma, Peritoneal Neoplasms

NCT00454519 2009-02-13

IPHC

Wuhan University

Phase 2 Unknown
60 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Neoplasm Metastasis, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡